Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue

Journal of Neural Transmission

Volumn 98, Issue 3, 1994, Pages 217-235

  Hansson, L O ^a   Waters, N ^b   Winblad, B ^c   Gottfries, C G ^d   Carlsson, A ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

heterogeneity; monoamines; multivariate analysis; Schizophrenia

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; BRAIN MONOAMINE; DOPA; DOPAMINE; MONOAMINE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; NORADRENALIN; NORMETADRENALIN; TYROSINE;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; FAMILY HISTORY; FEMALE; HEBEPHRENIA; HUMAN; HUMAN TISSUE; MALE; MULTIVARIATE ANALYSIS; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; ARTERIOSCLEROSIS; AUTOPSY; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; PSYCHOSURGERY; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEX DISTRIBUTION; SUPPORT, NON-U.S. GOV'T;

EID: 0028569126     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/BF01276538     Document Type: Article

References (32)

1. A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same tissue sample using column of strongly acidic cation exchange resin
2. Determination of monoamine and monoamine metabolites in the human brain: post-mortem studies in a group of suicides and in a control group
3. Postmortal accumulation of 3-MT in brain
4. Seasonal and circadian monoamine variations in human brains examined post mortem
5. Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease
6. The probability of chance correlation using partial least squares (PLS)
7. Neurotransmitter hypothesis of schizophrenia
8. Pattern recognition techniques in drug design
9. Norepinephrine in chronic paranoid schizophrenia
10. Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls
11. Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and homovanillic acid in brain tissue from an autopsy material
12. Classification of human cancer cells by means of capillary gas chromatography and pattern recognition analysis
13. Pyramidical model of schizophrenia
14. What are our criteria for a diagnosis of schizophrenia?
15. Glutamic acid and the dopamine hypothesis of schizophrenia
16. Postmortem neurochemistry studies in schizophrenia
17. Zur biochemischen Theorie der Schizophrenie
18. [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
19. Neurochemistry and neuroendocrinology of schizophrenia: a selective review
20. Dopamine D4 receptors elevated in schizophrenia
21. PLS discriminant plots
22. Cross validatory choice and assessment of statistical predictions
23. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients
24. The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity
25. Altered transport of tyrosine across the blood-brain barrier in patients with schizophrenia
26. Monoamines and monoamine metabolites in brains from demented shizophrenics
27. Soft modelling by latent variables; the non-linear iterative partial least squares approach
28. Cross-validatory estimation of the number of components in factor and principal component models